Pediatric Transplantation · 2007 · 24 citations · 21 references
PharmacyCardiologyPharmacotherapyCardiac TransplantationTransplant PharmacotherapyTransplant SurgeryCalcineurin Inhibitor TherapyCalcineurin InhibitorsLiver Transplant ImmunosuppressionMtor Inhibitor TherapyPediatric CardiomyopathyTransplant PharmacologyBiologic ImmunosuppressionHypertrophic Cardiomyopathy Drug TherapyPediatric Solid Organ TransplantationPharmacologic ImmunosuppressionTacrolimus Therapy
Tacrolimus (Tac)-related hypertrophic cardiomyopathy (HCM) has been reported to be an unusual but serious complication affecting pediatric patients after solid organ transplantation. Herein, we present a case of young liver transplant recipient with Tac-induced HCM, treated by discontinuation of Tac followed by conversion to rapamycin (Rap). Our case report points out the potential but rather low risk of HCM during Tac immunosuppression in pediatric liver transplants and demonstrates that replacement of calcineurin inhibitors with mammalian target of Rap (mTOR) inhibitors may be an efficacious therapeutic tool to effect regression of established cardiac hypertrophy.
21
Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients
Paul Atkison, G Joubert, Antony Barron et al. · The Lancet · 1995 · 204 citations
Medicine, Cardiology, Pediatrics +14